Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Myriad Genetics Inc MYGN

Healthcare Biotechnology
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight.


NDAQ:MYGN - Post by User

Myriad Genetics Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by nickmessaro02on Jan 10, 2009 9:26am
565 Views
Post# 15696000

Myriad Genetics Inc. Options

Myriad Genetics Inc. Options

On 01/12/09 Myriad Genetics Inc. options ( MYGN )

are used as an example of market neutral investing

on PERSONALHEDGEFUNDS.COM.

Hedge fund managers use options to increase profits

with limited risk.

The Myriad Genetics Inc. example shows how options are

used to generate profits each month from

FEBRUARY 2009 TO MAY 2009

Hedge fund manages use this technique to limit loss

and maximize profit.

Check out how they use Myriad Genetics Inc. options

to achieve market neutral investing.

https://www.personalhedgefunds.com

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities